Mendelian randomization analysis identified potential genes pleiotropically associated with polycystic ovary syndrome - Sun, Qian; Yuan, Gao; Yang, Jingyun; Lu, Jiayi; Feng, Wen; Yang, Wen (medRxiv, 2021)
Research question Polycystic ovary syndrome (PCOS) is a common endocrine disorder with unclear etiology. Are there any genes that are pleiotropically or potentially causally associated with PCOS?Design We applied the summary data-based Mendelian randomization (SMR) method integrating genome-wide association study (GWAS) for PCOS and expression quantitative trait loci (eQTL) data to identify genes that were pleiotropically associated with PCOS. We performed separate SMR analysis using eQTL data in the ovary and whole blood.Results Although no genes showed significant pleiotropic association with PCOS after correction for multiple testing, some of the genes exhibited suggestive significance. RPS26 showed the strongest suggestive pleiotropic association with PCOS in both SMR analyses (β[SE]=0.10[0.03], PSMR=1.72 exttimes10-4 for ovary; β[SE]=0.11[0.03], PSMR=1.40 exttimes10-4 for whole blood). PM20D1 showed the second strongest suggestive pleiotropic association with PCOS in the SMR analysis using eQTL data for the whole blood, and was also among the top ten hit genes in the SMR analysis using eQTL data for the ovary. Two other genes, including CTC-457L16.2 and NEIL2, were among the top ten hit genes in both SMR analyses.Conclusion We identified multiple genes that were potentially involved in the pathogenesis of PCOS. Our findings provided helpful leads to a better understanding of the mechanisms underlying PCOS, and revealed potential therapeutic targets for the effective treatment of PCOS.KEY MESSAGE Polycystic ovary syndrome (PCOS) is a common endocrine disorder, and its etiology can be multifaceted. We found that multiple genes were potentially involved in the pathogenesis of PCOS. The findings revealed the genetic mechanisms underlying PCOS and potential therapeutic targets for the effective treatment of PCOS.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.r-project.org/ https://www.cog-genomics.org/plink/1.9/ https://cnsgenomics.com/software/smr/ Funding StatementThis work was supported by Lianyungang Health and Family Planning Science and Technology Project (No. 201706). Dr Jingyun Yang’s research was supported by NIH/NIA grants [P30AG10161, R01AG15819, R01AG17917, R01AG36042, U01AG61356 and 1RF1AG064312-01].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was approved by the Ethics committee of the First Affiliated Hospital of Kangda College of Nanjing Medical University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are publicly available as specified in the methods section of this paper. The eQTL data can be downloaded at https://cnsgenomics.com/data/SMR/#eQTLsummarydata, and the GWAS summarized data can be downloaded at https://www.repository.cam.ac.uk/handle/1810/283491.BPABisphenol A;eQTLexpression quantitative trait loci;GWASgenome-wide association study;HEIDIheterogeneity in dependent instruments;IRinsulin resistance;MRmendelian randomization;PCOSpolycystic ovary syndrome;QoLquality of life;SMRsummary data-based Mendelian randomization